Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependence.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000654:Amobarbital / Q000627:therapeutic use; D002697:Chloral Hydrate / Q000627:therapeutic use; D002908:Chronic Disease; D004325:Dreams / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D005479:Flurazepam / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010424:Pentobarbital / Q000627:therapeutic use; D012631:Secobarbital / Q000627:therapeutic use; D012892:Sleep Deprivation; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D012895:Sleep, REM / Q000187:drug effects; D012964:Sodium / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders; D013997:Time Factors; D014851:Wakefulness
D006993:Hypnotics and Sedatives; D012631:Secobarbital; D002697:Chloral Hydrate; D012964:Sodium; D000654:Amobarbital; D010424:Pentobarbital; D005479:Flurazepam